One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...
Study looks at benefits and risks to popular weight-loss drugs; Kentucky leads nation in use of them
By Melissa Patrick and Liberty Gilbert Kentucky Health News Whether it is prescribed for diabetes or weight loss, Ozempic and ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...
7d
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback